Frequent hypermethylation of the RASSF1A gene in prostate cancer.
about
Epigenetic modulators as therapeutic targets in prostate cancerThe Ras-association domain family (RASSF) members and their role in human tumourigenesis.Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation.Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosisEpigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors.Oxidative stress and DNA methylation in prostate cancer.RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1.Epigenetic changes in prostate cancer: implication for diagnosis and treatment.Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinomaDown-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration.Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels.Aberrant DNA methylation and prostate cancer.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Applicability of biomarkers in the early diagnosis of prostate cancer.Clinical utility of RASSF1A methylation in human malignancies.Epigenetic regulation of prostate cancerDNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer CellsMolecular prostate cancer pathology: current issues and achievements.Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylationEpigenetic alterations in human prostate cancers.Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cellsProstate cancer epigenetics: a review on gene regulation.Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK.Promoter hypermethylation in prostate cancer.The cellular functions of RASSF1A and its inactivation in prostate cancer.Urinary biomarkers for prostate cancer: a review.Circulating nucleic acids as biomarkers of prostate cancer.Epigenetic modifications in prostate cancer.A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation.Identification and characterization of RASSF1C piRNA target genes in lung cancer cells.Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin.Molecular and physiological mechanisms of membrane receptor systems functioning.DNA methylation in promoter region as biomarkers in prostate cancer.Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysisAssociation of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies.
P2860
Q28071912-FDF79AFD-BEB0-4E3D-8C16-D904E9ADDE0EQ31121564-223121FA-5CC2-4C29-BE88-4D09D0DD9A46Q33218593-546EEEC4-DBA1-427D-A931-B9A02354712EQ33721470-D4CBCEC5-ABDF-48B6-AC62-72EC81473889Q33838513-62D2201A-CAB7-461A-BDE3-CC0FC9D1ED40Q33991964-8D9AFC3B-8CC5-458F-AF81-67F704301370Q34021985-5C3EBCA7-1A71-4933-A391-65B218962452Q34271675-073F7B1C-AD93-4856-917B-B9D8D4A9A040Q34385658-BC4237DF-E450-4362-9FF1-71DFE32B892DQ34605107-6A458185-5737-4002-83A1-EF038806BB7FQ34829786-D6DB31A0-64F5-40BE-93CD-FCC8D089BCD3Q35203738-A9C076F9-4987-44CB-B4C6-DF93B0684FFBQ35560819-3CC5AC0E-B3E5-4EF9-A9DD-2E3D8139ABE7Q35636543-1EF24003-6B8E-4B9E-BD31-A87EF7251DC1Q35821838-15B7EECF-9605-40F7-B859-273F9C71CCB9Q35909621-1498019E-47AE-4927-B391-E0BAAE96317DQ36001910-0E51728D-DFEF-4011-B18A-E93B1D0D1BE2Q36190050-43E6EE5E-1B76-4A07-B180-6AFE09209CBEQ36194970-A0247201-AD60-439F-99F8-5E9ED98F9FEFQ36517724-52D375C0-8F1F-4214-BF9C-143D64B71461Q36571511-26D7BBE1-50F8-463E-B285-1A2D19524209Q36695645-97A258A3-DF7D-469A-8E52-F6E1CE1957AEQ37328845-4BEF3E6A-7D40-487E-AADF-6D8B3D4B0032Q37365548-7BFF6BE5-6686-4663-B6F6-6E5873CDE3C1Q37380585-458E5667-3B78-4226-8813-B018A620C4D3Q37536803-156E5A41-3CBE-4221-9AA1-F0CCFC7B07F4Q37791396-35BD6858-F2A9-40F4-BCC2-AC20FD268D3EQ37996013-FA2EC97E-DACE-4A4A-9C99-0CC703F7CDDFQ38092578-05F0F98C-B0F1-4AF7-9F79-863640F8626CQ38165244-478844DC-7AFE-47A0-9CB0-CBD06EC4F278Q38261747-4F18B9A0-96E3-45A3-96EF-1E8C4760D50BQ38365327-82935615-825F-4C01-9515-C451DD1F39E5Q38706879-DADCE3A9-70B1-48EA-8B2B-15171FD076C8Q38733030-E720A51A-2038-4090-A0D4-A873C4399DBAQ41845384-99AD2182-702C-4EA5-A0AB-8B677BBDD47CQ42153161-F39CF04B-56A9-4B50-B28D-BA06F1A5820FQ42261678-C60A7E44-92D4-4A0F-B07A-610E4EF61792Q42687929-9E2082B3-A6B9-41F5-8F6B-2B621DA2AF94Q44284047-B011C730-9A72-497F-B676-ECFEB7BC5868Q44538170-DAFE25FA-21B8-4BBF-A057-6700A0AA3147
P2860
Frequent hypermethylation of the RASSF1A gene in prostate cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Frequent hypermethylation of the RASSF1A gene in prostate cancer.
@en
type
label
Frequent hypermethylation of the RASSF1A gene in prostate cancer.
@en
prefLabel
Frequent hypermethylation of the RASSF1A gene in prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Frequent hypermethylation of the RASSF1A gene in prostate cancer.
@en
P2093
Gerd P Pfeifer
Jung-Hoon Yoon
Reinhard Dammann
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205814
P407
P577
2002-10-01T00:00:00Z
P5875
P6179
1019689879